{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:28:27Z","timestamp":1790742507853,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T00:00:00Z","timestamp":1683331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T00:00:00Z","timestamp":1683331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"CIHR Institute of Gender and Health","award":["WHC-169726"],"award-info":[{"award-number":["WHC-169726"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To examine the effects of Hodgkin\u2019s lymphoma and its treatment on reproductive health in female adolescent and young adults (AYA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a retrospective, population-based, matched-cohort study of female patients with Hodgkin\u2019s lymphoma diagnosed at 15\u201339\u00a0years of age from 1995 to 2014 in Ontario, Canada. Three female individuals with no history of cancer (unexposed) were matched by birth year and census subdivision to each patient with cancer (exposed). In a subset of the cohort (2005 onwards), the Hodgkin\u2019s lymphoma patients were further classified into two groups for analysis based on treatment exposure: (1) chemotherapy alone or (2) combined chemotherapy and radiation. Reproductive health outcomes were infertility, childbirth, and premature ovarian insufficiency (POI). Relative risks (RR) were calculated using modified Poisson regression adjusted for income quintile, immigration status, and parity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 1443 exposed and 4329 unexposed individuals formed our cohort. Hodgkin\u2019s lymphoma patients were at an increased risk of infertility (aRR 1.86; 95% CI 1.57 to 2.20) and POI (aRR 2.81; 95% CI 2.16 to 3.65). While the risk of infertility persisted in both treatment groups (chemotherapy alone, combined chemotherapy plus radiotherapy), the increased risk of POI was only statistically significant in the chemotherapy plus radiotherapy group. No differences in childbirth rates were observed, overall or by treatment exposure compared with unexposed individuals.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Female AYA survivors of Hodgkin\u2019s lymphoma face an increased risk of infertility, independent of exposure to chemotherapy alone, or chemotherapy plus radiotherapy. The risk of POI is higher in those requiring radiotherapy vs. chemotherapy alone.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Implications for cancer survivors<\/jats:title>\n                <jats:p>These results emphasize the importance of pre-treatment fertility counseling and reproductive health surveillance for AYAs diagnosed with Hodgkin\u2019s lymphoma.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11764-023-01388-z","type":"journal-article","created":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T04:01:33Z","timestamp":1683345693000},"page":"1434-1441","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Chemotherapy alone vs. chemotherapy plus radiotherapy in female adolescent and young adults with Hodgkin\u2019s lymphoma: reproductive health outcomes"],"prefix":"10.1007","volume":"18","author":[{"given":"Susan","family":"Luong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Mockler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Pudwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Dudebout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria P.","family":"Velez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,6]]},"reference":[{"issue":"6","key":"1388_CR1","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3322\/caac.21637","volume":"70","author":"KD Miller","year":"2020","unstructured":"Miller KD, Fidler-Benaoudia M, Keegan TH, Hipp HS, Jemal A, Siegel RL. Cancer statistics for adolescents and young adults, 2020. CA Cancer J Clin. 2020;70(6):443\u201359.","journal-title":"CA Cancer J Clin"},{"key":"1388_CR2","unstructured":"Canadian Cancer Statistics Advisory Committee. Canadian Cancer Statistics 2019. Toronto, ON: Canadian Cancer Society; 2019.\u00a0Available at:\u00a0http:\/\/cancer.ca\/Canadian-Cancer-Statistics-2019-EN (accessed 10\/12\/ 2022)."},{"key":"1388_CR3","doi-asserted-by":"crossref","unstructured":"Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Armand P, Bello CM, et al. Hodgkin Lymphoma, Version 2.2020,\u00a0NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020;18(6):755\u201381.","DOI":"10.6004\/jnccn.2020.0026"},{"issue":"3","key":"1388_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11899-007-0020-4","volume":"2","author":"MJ Adams","year":"2007","unstructured":"Adams MJ, Constine LS, Lipshultz SE. Late effects of therapy for Hodgkin\u2019s lymphoma. Curr Hematol Malig Rep. 2007;2(3):143\u201350.","journal-title":"Curr Hematol Malig Rep"},{"issue":"1","key":"1388_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12978-022-01559-8","volume":"20","author":"SB Flatt","year":"2023","unstructured":"Flatt SB, Baillargeon A, McClintock C, Pudwell J, Velez MP. Premature ovarian insufficiency in female adolescent and young adult survivors of non-gynecological cancers: a population-based cohort study. Reprod Health. 2023;20(1):4.","journal-title":"Reprod Health"},{"issue":"7","key":"1388_CR6","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1093\/humrep\/deab036","volume":"36","author":"MP Velez","year":"2021","unstructured":"Velez MP, Richardson H, Baxter NN, McClintock C, Greenblatt E, Barr R, et al. Risk of infertility in female adolescents and young adults with cancer: a population-based cohort study. Hum Reprod. 2021;36(7):1981\u20138.","journal-title":"Hum Reprod"},{"key":"1388_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1471-2407-13-30","volume":"13","author":"NN Baxter","year":"2013","unstructured":"Baxter NN, Sutradhar R, DelGuidice ME, Forbes S, Paszat LF, Wilton AS, et al. A population-based study of rates of childbirth in recurrence-free female young adult survivors of non-gynecologic malignancies. BMC Cancer. 2013;13:30.","journal-title":"BMC Cancer"},{"issue":"6","key":"1388_CR8","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S1470-2045(15)70140-3","volume":"16","author":"JH Bramswig","year":"2015","unstructured":"Bramswig JH, Riepenhausen M, Schellong G. Parenthood in adult female survivors treated for Hodgkin\u2019s lymphoma during childhood and adolescence: a prospective, longitudinal study. Lancet Oncol. 2015;16(6):667\u201375.","journal-title":"Lancet Oncol"},{"issue":"31","key":"1388_CR9","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1200\/JCO.21.00357","volume":"39","author":"AK Ovlisen","year":"2021","unstructured":"Ovlisen AK, Jakobsen LH, Eloranta S, Kragholm KH, Hutchings M, Frederiksen H, et al. Parenthood rates and use of assisted reproductive techniques in younger Hodgkin lymphoma survivors: a Danish population-based study. J Clin Oncol. 2021;39(31):3463\u201372.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1388_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1182\/blood-2007-05-090225","volume":"111","author":"ML De Bruin","year":"2008","unstructured":"De Bruin ML, Huisbrink J, Hauptmann M, Kuenen MA, Ouwens GM, van\u2019t Veer MB, et al. Treatment-related risk factors for premature menopause following Hodgkin lymphoma. Blood. 2008;111(1):101\u20138.","journal-title":"Blood"},{"issue":"23","key":"1388_CR11","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1056\/NEJM198106043042301","volume":"304","author":"SJ Horning","year":"1981","unstructured":"Horning SJ, Hoppe RT, Kaplan HS, Rosenberg SA. Female reproductive potential after treatment for Hodgkin\u2019s disease. N Engl J Med. 1981;304(23):1377\u201382.","journal-title":"N Engl J Med"},{"key":"1388_CR12","doi-asserted-by":"crossref","unstructured":"Swerdlow AJ, Cooke R, Bates A, Cunningham D, Falk SJ, Gilson D, et al. Risk of premature menopause after treatment for Hodgkin\u2019s lymphoma.\u00a0J Natl Cancer Inst.\u00a02014;106(9):dju207.","DOI":"10.1093\/jnci\/dju207"},{"issue":"25","key":"1388_CR13","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","volume":"28","author":"PC Austin","year":"2009","unstructured":"Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083\u2013107.","journal-title":"Stat Med"},{"issue":"23\u201324","key":"1388_CR14","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1111\/jocn.12354","volume":"22","author":"CM Eeltink","year":"2013","unstructured":"Eeltink CM, Incrocci L, Witte BI, Meurs S, Visser O, Huijgens P, et al. Fertility and sexual function in female Hodgkin lymphoma survivors of reproductive age. J Clin Nurs. 2013;22(23\u201324):3513\u201321.","journal-title":"J Clin Nurs"},{"issue":"19","key":"1388_CR15","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1200\/JCO.2018.78.1914","volume":"36","author":"K Oktay","year":"2018","unstructured":"Oktay K, Harvey BE, Partridge AH, Quinn GP, Reinecke J, Taylor HS, et al. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2018;36(19):1994\u20132001.","journal-title":"J Clin Oncol"},{"issue":"19","key":"1388_CR16","doi-asserted-by":"publisher","first-page":"6933","DOI":"10.1002\/cam4.3138","volume":"9","author":"S Gupta","year":"2020","unstructured":"Gupta S, Baxter NN, Hodgson D, Punnett A, Sutradhar R, Pole JD, et al. Treatment patterns and outcomes in adolescents and young adults with Hodgkin lymphoma in pediatric versus adult centers: An IMPACT Cohort Study. Cancer Med. 2020;9(19):6933\u201345.","journal-title":"Cancer Med"},{"issue":"8","key":"1388_CR17","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1080\/00016340600677043","volume":"85","author":"SI Verschuuren","year":"2006","unstructured":"Verschuuren SI, Schaap JJ, Veer MB, Stijnen T, Burger CW, Ansink AC. Optimal treatment of premature ovarian failure after treatment for Hodgkin\u2019s lymphoma is often withheld. Acta Obstet Gynecol Scand. 2006;85(8):997\u20131002.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"9","key":"1388_CR18","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1093\/annonc\/mdl149","volume":"17","author":"UK Haukvik","year":"2006","unstructured":"Haukvik UK, Dieset I, Bjoro T, Holte H, Fossa SD. Treatment-related premature ovarian failure as a long-term complication after Hodgkin\u2019s lymphoma. Ann Oncol. 2006;17(9):1428\u201333.","journal-title":"Ann Oncol"},{"issue":"11","key":"1388_CR19","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.3324\/haematol.2011.045856","volume":"96","author":"S Harel","year":"2011","unstructured":"Harel S, Ferme C, Poirot C. Management of fertility in patients treated for Hodgkin\u2019s lymphoma. Haematologica. 2011;96(11):1692\u20139.","journal-title":"Haematologica"},{"issue":"4","key":"1388_CR20","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/hon.939","volume":"28","author":"MA van der Kaaij","year":"2010","unstructured":"van der Kaaij MA, van Echten-Arends J, Simons AH, Kluin-Nelemans HC. Fertility preservation after chemotherapy for Hodgkin lymphoma. Hematol Oncol. 2010;28(4):168\u201379.","journal-title":"Hematol Oncol"},{"issue":"8","key":"1388_CR21","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3109\/09513590.2013.797402","volume":"29","author":"A Gadducci","year":"2013","unstructured":"Gadducci A, Tana R, Sergiampietri C, Guiggi I. Fertility outcome of breast cancer and Hodgkin\u2019s lymphoma female survivors: a growing clinical challenge for gynecologists and oncologists. Gynecol Endocrinol. 2013;29(8):729\u201334.","journal-title":"Gynecol Endocrinol"},{"issue":"11","key":"1388_CR22","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/OGX.0000000000000835","volume":"75","author":"ML Hutchcraft","year":"2020","unstructured":"Hutchcraft ML, McCracken K, Whiteside S, Lustberg M, Lindheim SR, Nahata L, et al. Current fertility preservation options for female patients with Hodgkin lymphoma. Obstet Gynecol Surv. 2020;75(11):683\u201391.","journal-title":"Obstet Gynecol Surv"},{"issue":"10","key":"1388_CR23","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/S1470-2045(18)30500-X","volume":"19","author":"RA Anderson","year":"2018","unstructured":"Anderson RA, Remedios R, Kirkwood AA, Patrick P, Stevens L, Clifton-Hadley L, et al. Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin\u2019s lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial. Lancet Oncol. 2018;19(10):1328\u201337.","journal-title":"Lancet Oncol"},{"issue":"30","key":"1388_CR24","doi-asserted-by":"publisher","first-page":"7555","DOI":"10.1200\/JCO.2005.08.138","volume":"23","author":"K Behringer","year":"2005","unstructured":"Behringer K, Breuer K, Reineke T, May M, Nogova L, Klimm B, et al. Secondary amenorrhea after Hodgkin\u2019s lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin\u2019s lymphoma study group. J Clin Oncol. 2005;23(30):7555\u201364.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1388_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/hon.802","volume":"25","author":"DC Hodgson","year":"2007","unstructured":"Hodgson DC, Pintilie M, Gitterman L, Dewitt B, Buckley CA, Ahmed S, et al. Fertility among female hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy. Hematol Oncol. 2007;25(1):11\u20135.","journal-title":"Hematol Oncol"},{"issue":"4","key":"1388_CR26","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/(SICI)1097-0142(19990815)86:4<697::AID-CNCR20>3.0.CO;2-J","volume":"86","author":"LR Schover","year":"1999","unstructured":"Schover LR, Rybicki LA, Martin BA, Bringelsen KA. Having children after cancer. A pilot survey of survivors\u2019 attitudes and experiences. Cancer. 1999;86(4):697\u2013709.","journal-title":"Cancer"},{"issue":"3","key":"1388_CR27","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1089\/jayao.2020.0101","volume":"10","author":"CEM Coleman","year":"2021","unstructured":"Coleman CEM, Pudwell J, McClintock C, Korkidakis A, Green M, Velez MP. Modest increase in fertility consultations in female adolescents and young adults with lymphoma: a population-based study. J Adolesc Young Adult Oncol. 2021;10(3):342\u20135.","journal-title":"J Adolesc Young Adult Oncol"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-023-01388-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11764-023-01388-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-023-01388-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T09:27:45Z","timestamp":1723627665000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11764-023-01388-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,6]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["1388"],"URL":"https:\/\/doi.org\/10.1007\/s11764-023-01388-z","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,6]]},"assertion":[{"value":"11 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Queen\u2019s University Health Sciences and Affiliated Teaching Hospitals Research Ethics Board (File #OBGY-296\u201316).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"ICES is a prescribed entity under Ontario\u2019s Personal Health Information Protection Act (PHIPA). Section\u00a045 of PHIPA authorizes ICES to collect personal health information, without consent, for the purpose of analysis or compiling statistical information with respect to the management of, evaluation or monitoring of, the allocation of resources to or planning for all or part of the health system.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}